SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-288500
Filing Date
2020-11-09
Accepted
2020-11-09 07:41:23
Documents
56
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d204131d10q.htm   iXBRL 10-Q 1348061
2 EX-31.1 d204131dex311.htm EX-31.1 11186
3 EX-31.2 d204131dex312.htm EX-31.2 11208
4 EX-32.1 d204131dex321.htm EX-32.1 4940
5 EX-32.2 d204131dex322.htm EX-32.2 4961
  Complete submission text file 0001193125-20-288500.txt   4365610

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA galt-20200930.xsd EX-101.SCH 36543
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20200930_cal.xml EX-101.CAL 21432
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20200930_def.xml EX-101.DEF 252783
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20200930_lab.xml EX-101.LAB 304034
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20200930_pre.xml EX-101.PRE 287274
11 EXTRACTED XBRL INSTANCE DOCUMENT d204131d10q_htm.xml XML 449601
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 201296122
SIC: 2834 Pharmaceutical Preparations